New England Journal of Medicine Case Study Reveals New Information about Advanced Melanoma Treatment

Add a Comment By Memorial Sloan-Kettering   |  Friday, December 7, 2012 Memorial Sloan-Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma. read more

View original post here:
New England Journal of Medicine Case Study Reveals New Information about Advanced Melanoma Treatment

Share and Enjoy:
  • Print
  • Digg
  • StumbleUpon
  • Facebook
  • Yahoo! Buzz
  • Twitter
  • Google Bookmarks
  • Add to favorites
  • email
  • LinkedIn
  • RSS
  • Tumblr
Share